Acknowledgments The authors want to thank all of the children and their parents for participation in the palatability assessment. They also want to thank Marieke Roskam-Kwint for assistance in the performance of the palatability assessment.Peer reviewedPublisher PDFPublisher PD
The development of medicines designed for children can be challenging since this distinct patient po...
Objective To evaluate the age appropriateness and suitability of patient-reported outcome measures t...
© American Association of Pharmaceutical Scientists 2016, published by Springer US, available online...
Aims: The palatability of a new paediatric formulation of valaciclovir was assessed in children and ...
Introduction: Children often reject non-palatable medications. Pediatric formulations contain sweete...
Objectives: The aim of this review was to map the currently available evidence on acceptability of o...
Drug development for children has long been a neglected area compared to adult drug development. The...
An industry-based survey was conducted by the Global Alliance for Pediatric Therapeutics in February...
A medicine will not elicit its desired therapeutic effect if the patient is not able or willing to t...
Drug therapy for children is one of the cornerstone developments that have sharply reduced childhood...
The complex process of oral drug absorption is influenced by a host of drug and formulation properti...
Children frequently receive medicines that are designed for adults. The dose of commercially availab...
Accurate dosing of the right medicine to the right patient is a key element of safe and efficacious ...
Background: The palatability of flucloxacillin oral liquid is poor. Parents/carers use strategies to...
Background: Regulatory guidelines require that any new medicine designed for a pediatric population ...
The development of medicines designed for children can be challenging since this distinct patient po...
Objective To evaluate the age appropriateness and suitability of patient-reported outcome measures t...
© American Association of Pharmaceutical Scientists 2016, published by Springer US, available online...
Aims: The palatability of a new paediatric formulation of valaciclovir was assessed in children and ...
Introduction: Children often reject non-palatable medications. Pediatric formulations contain sweete...
Objectives: The aim of this review was to map the currently available evidence on acceptability of o...
Drug development for children has long been a neglected area compared to adult drug development. The...
An industry-based survey was conducted by the Global Alliance for Pediatric Therapeutics in February...
A medicine will not elicit its desired therapeutic effect if the patient is not able or willing to t...
Drug therapy for children is one of the cornerstone developments that have sharply reduced childhood...
The complex process of oral drug absorption is influenced by a host of drug and formulation properti...
Children frequently receive medicines that are designed for adults. The dose of commercially availab...
Accurate dosing of the right medicine to the right patient is a key element of safe and efficacious ...
Background: The palatability of flucloxacillin oral liquid is poor. Parents/carers use strategies to...
Background: Regulatory guidelines require that any new medicine designed for a pediatric population ...
The development of medicines designed for children can be challenging since this distinct patient po...
Objective To evaluate the age appropriateness and suitability of patient-reported outcome measures t...
© American Association of Pharmaceutical Scientists 2016, published by Springer US, available online...